Global Veterinary Vaccines Market Insights, Forecast to 2031

Report ID: 1653311 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Inactivated Vaccines
        1.2.3 Live Attenuated Vaccines
        1.2.4 Conjugate Vaccines
        1.2.5 Toxoid Vaccines
        1.2.6 Recombinant Vaccines
        1.2.7 DNA Vaccines
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Veterinary Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Veterinary Clinic
        1.3.3 Veterinary Hospital
        1.3.4 Veterinary Research Institute
        1.3.5 Retail Pharmacy
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Veterinary Vaccines Market Perspective (2017-2028)
    2.2 Veterinary Vaccines Growth Trends by Region
        2.2.1 Veterinary Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Veterinary Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 Veterinary Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 Veterinary Vaccines Market Dynamics
        2.3.1 Veterinary Vaccines Industry Trends
        2.3.2 Veterinary Vaccines Market Drivers
        2.3.3 Veterinary Vaccines Market Challenges
        2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Veterinary Vaccines Players by Revenue
        3.1.1 Global Top Veterinary Vaccines Players by Revenue (2017-2022)
        3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
    3.4 Global Veterinary Vaccines Market Concentration Ratio
        3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2021
    3.5 Veterinary Vaccines Key Players Head office and Area Served
    3.6 Key Players Veterinary Vaccines Product Solution and Service
    3.7 Date of Enter into Veterinary Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
    4.1 Global Veterinary Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028)
5 Veterinary Vaccines Breakdown Data by Application
    5.1 Global Veterinary Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Veterinary Vaccines Market Size (2017-2028)
    6.2 North America Veterinary Vaccines Market Size by Type
        6.2.1 North America Veterinary Vaccines Market Size by Type (2017-2022)
        6.2.2 North America Veterinary Vaccines Market Size by Type (2023-2028)
        6.2.3 North America Veterinary Vaccines Market Share by Type (2017-2028)
    6.3 North America Veterinary Vaccines Market Size by Application
        6.3.1 North America Veterinary Vaccines Market Size by Application (2017-2022)
        6.3.2 North America Veterinary Vaccines Market Size by Application (2023-2028)
        6.3.3 North America Veterinary Vaccines Market Share by Application (2017-2028)
    6.4 North America Veterinary Vaccines Market Size by Country
        6.4.1 North America Veterinary Vaccines Market Size by Country (2017-2022)
        6.4.2 North America Veterinary Vaccines Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Veterinary Vaccines Market Size (2017-2028)
    7.2 Europe Veterinary Vaccines Market Size by Type
        7.2.1 Europe Veterinary Vaccines Market Size by Type (2017-2022)
        7.2.2 Europe Veterinary Vaccines Market Size by Type (2023-2028)
        7.2.3 Europe Veterinary Vaccines Market Share by Type (2017-2028)
    7.3 Europe Veterinary Vaccines Market Size by Application
        7.3.1 Europe Veterinary Vaccines Market Size by Application (2017-2022)
        7.3.2 Europe Veterinary Vaccines Market Size by Application (2023-2028)
        7.3.3 Europe Veterinary Vaccines Market Share by Application (2017-2028)
    7.4 Europe Veterinary Vaccines Market Size by Country
        7.4.1 Europe Veterinary Vaccines Market Size by Country (2017-2022)
        7.4.2 Europe Veterinary Vaccines Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Veterinary Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific Veterinary Vaccines Market Size by Type
        8.2.1 Asia-Pacific Veterinary Vaccines Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Veterinary Vaccines Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Veterinary Vaccines Market Share by Type (2017-2028)
    8.3 Asia-Pacific Veterinary Vaccines Market Size by Application
        8.3.1 Asia-Pacific Veterinary Vaccines Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Veterinary Vaccines Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Veterinary Vaccines Market Share by Application (2017-2028)
    8.4 Asia-Pacific Veterinary Vaccines Market Size by Region
        8.4.1 Asia-Pacific Veterinary Vaccines Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Veterinary Vaccines Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Veterinary Vaccines Market Size (2017-2028)
    9.2 Latin America Veterinary Vaccines Market Size by Type
        9.2.1 Latin America Veterinary Vaccines Market Size by Type (2017-2022)
        9.2.2 Latin America Veterinary Vaccines Market Size by Type (2023-2028)
        9.2.3 Latin America Veterinary Vaccines Market Share by Type (2017-2028)
    9.3 Latin America Veterinary Vaccines Market Size by Application
        9.3.1 Latin America Veterinary Vaccines Market Size by Application (2017-2022)
        9.3.2 Latin America Veterinary Vaccines Market Size by Application (2023-2028)
        9.3.3 Latin America Veterinary Vaccines Market Share by Application (2017-2028)
    9.4 Latin America Veterinary Vaccines Market Size by Country
        9.4.1 Latin America Veterinary Vaccines Market Size by Country (2017-2022)
        9.4.2 Latin America Veterinary Vaccines Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Veterinary Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa Veterinary Vaccines Market Size by Type
        10.2.1 Middle East & Africa Veterinary Vaccines Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Veterinary Vaccines Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Veterinary Vaccines Market Share by Type (2017-2028)
    10.3 Middle East & Africa Veterinary Vaccines Market Size by Application
        10.3.1 Middle East & Africa Veterinary Vaccines Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Veterinary Vaccines Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Veterinary Vaccines Market Share by Application (2017-2028)
    10.4 Middle East & Africa Veterinary Vaccines Market Size by Country
        10.4.1 Middle East & Africa Veterinary Vaccines Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Elanco
        11.1.1 Elanco Company Details
        11.1.2 Elanco Business Overview
        11.1.3 Elanco Veterinary Vaccines Introduction
        11.1.4 Elanco Revenue in Veterinary Vaccines Business (2017-2022)
        11.1.5 Elanco Recent Developments
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Veterinary Vaccines Introduction
        11.2.4 Merck Revenue in Veterinary Vaccines Business (2017-2022)
        11.2.5 Merck Recent Developments
    11.3 Merial
        11.3.1 Merial Company Details
        11.3.2 Merial Business Overview
        11.3.3 Merial Veterinary Vaccines Introduction
        11.3.4 Merial Revenue in Veterinary Vaccines Business (2017-2022)
        11.3.5 Merial Recent Developments
    11.4 Zoetis
        11.4.1 Zoetis Company Details
        11.4.2 Zoetis Business Overview
        11.4.3 Zoetis Veterinary Vaccines Introduction
        11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2017-2022)
        11.4.5 Zoetis Recent Developments
    11.5 Advaxis
        11.5.1 Advaxis Company Details
        11.5.2 Advaxis Business Overview
        11.5.3 Advaxis Veterinary Vaccines Introduction
        11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2017-2022)
        11.5.5 Advaxis Recent Developments
    11.6 AmpliPhi Biosciences
        11.6.1 AmpliPhi Biosciences Company Details
        11.6.2 AmpliPhi Biosciences Business Overview
        11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
        11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022)
        11.6.5 AmpliPhi Biosciences Recent Developments
    11.7 Aratana Therapeutics
        11.7.1 Aratana Therapeutics Company Details
        11.7.2 Aratana Therapeutics Business Overview
        11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
        11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
        11.7.5 Aratana Therapeutics Recent Developments
    11.8 ARKO Labs
        11.8.1 ARKO Labs Company Details
        11.8.2 ARKO Labs Business Overview
        11.8.3 ARKO Labs Veterinary Vaccines Introduction
        11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022)
        11.8.5 ARKO Labs Recent Developments
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Veterinary Vaccines Introduction
        11.9.4 Bayer Revenue in Veterinary Vaccines Business (2017-2022)
        11.9.5 Bayer Recent Developments
    11.10 CanFel Therapeutics
        11.10.1 CanFel Therapeutics Company Details
        11.10.2 CanFel Therapeutics Business Overview
        11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
        11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
        11.10.5 CanFel Therapeutics Recent Developments
    11.11 Ceva Animal Health
        11.11.1 Ceva Animal Health Company Details
        11.11.2 Ceva Animal Health Business Overview
        11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
        11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022)
        11.11.5 Ceva Animal Health Recent Developments
    11.12 Colorado Serum
        11.12.1 Colorado Serum Company Details
        11.12.2 Colorado Serum Business Overview
        11.12.3 Colorado Serum Veterinary Vaccines Introduction
        11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022)
        11.12.5 Colorado Serum Recent Developments
    11.13 Epitopix
        11.13.1 Epitopix Company Details
        11.13.2 Epitopix Business Overview
        11.13.3 Epitopix Veterinary Vaccines Introduction
        11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2017-2022)
        11.13.5 Epitopix Recent Developments
    11.14 Genus
        11.14.1 Genus Company Details
        11.14.2 Genus Business Overview
        11.14.3 Genus Veterinary Vaccines Introduction
        11.14.4 Genus Revenue in Veterinary Vaccines Business (2017-2022)
        11.14.5 Genus Recent Developments
    11.15 Hygieia Biological Laboratories
        11.15.1 Hygieia Biological Laboratories Company Details
        11.15.2 Hygieia Biological Laboratories Business Overview
        11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
        11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022)
        11.15.5 Hygieia Biological Laboratories Recent Developments
    11.16 ImmuCell
        11.16.1 ImmuCell Company Details
        11.16.2 ImmuCell Business Overview
        11.16.3 ImmuCell Veterinary Vaccines Introduction
        11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2017-2022)
        11.16.5 ImmuCell Recent Developments
    11.17 Nexvet
        11.17.1 Nexvet Company Details
        11.17.2 Nexvet Business Overview
        11.17.3 Nexvet Veterinary Vaccines Introduction
        11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2017-2022)
        11.17.5 Nexvet Recent Developments
    11.18 Nuovo Biologics
        11.18.1 Nuovo Biologics Company Details
        11.18.2 Nuovo Biologics Business Overview
        11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
        11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022)
        11.18.5 Nuovo Biologics Recent Developments
    11.19 UBI
        11.19.1 UBI Company Details
        11.19.2 UBI Business Overview
        11.19.3 UBI Veterinary Vaccines Introduction
        11.19.4 UBI Revenue in Veterinary Vaccines Business (2017-2022)
        11.19.5 UBI Recent Developments
    11.20 Valneva
        11.20.1 Valneva Company Details
        11.20.2 Valneva Business Overview
        11.20.3 Valneva Veterinary Vaccines Introduction
        11.20.4 Valneva Revenue in Veterinary Vaccines Business (2017-2022)
        11.20.5 Valneva Recent Developments
    11.21 Vetoquinol
        11.21.1 Vetoquinol Company Details
        11.21.2 Vetoquinol Business Overview
        11.21.3 Vetoquinol Veterinary Vaccines Introduction
        11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022)
        11.21.5 Vetoquinol Recent Developments
    11.22 Virbac
        11.22.1 Virbac Company Details
        11.22.2 Virbac Business Overview
        11.22.3 Virbac Veterinary Vaccines Introduction
        11.22.4 Virbac Revenue in Veterinary Vaccines Business (2017-2022)
        11.22.5 Virbac Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Inactivated Vaccines
    Table 3. Key Players of Live Attenuated Vaccines
    Table 4. Key Players of Conjugate Vaccines
    Table 5. Key Players of Toxoid Vaccines
    Table 6. Key Players of Recombinant Vaccines
    Table 7. Key Players of DNA Vaccines
    Table 8. Key Players of Others
    Table 9. Global Veterinary Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Veterinary Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Veterinary Vaccines Market Share by Region (2017-2022)
    Table 13. Global Veterinary Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Veterinary Vaccines Market Share by Region (2023-2028)
    Table 15. Veterinary Vaccines Market Trends
    Table 16. Veterinary Vaccines Market Drivers
    Table 17. Veterinary Vaccines Market Challenges
    Table 18. Veterinary Vaccines Market Restraints
    Table 19. Global Veterinary Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Veterinary Vaccines Revenue Share by Players (2017-2022)
    Table 21. Global Top Veterinary Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
    Table 22. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Veterinary Vaccines Product Solution and Service
    Table 26. Date of Enter into Veterinary Vaccines Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Veterinary Vaccines Revenue Market Share by Type (2017-2022)
    Table 30. Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Veterinary Vaccines Revenue Market Share by Type (2023-2028)
    Table 32. Global Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Veterinary Vaccines Revenue Share by Application (2017-2022)
    Table 34. Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Veterinary Vaccines Revenue Share by Application (2023-2028)
    Table 36. North America Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Veterinary Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Veterinary Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Veterinary Vaccines Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Veterinary Vaccines Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Veterinary Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Veterinary Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Elanco Company Details
    Table 67. Elanco Business Overview
    Table 68. Elanco Veterinary Vaccines Product
    Table 69. Elanco Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 70. Elanco Recent Developments
    Table 71. Merck Company Details
    Table 72. Merck Business Overview
    Table 73. Merck Veterinary Vaccines Product
    Table 74. Merck Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 75. Merck Recent Developments
    Table 76. Merial Company Details
    Table 77. Merial Business Overview
    Table 78. Merial Veterinary Vaccines Product
    Table 79. Merial Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 80. Merial Recent Developments
    Table 81. Zoetis Company Details
    Table 82. Zoetis Business Overview
    Table 83. Zoetis Veterinary Vaccines Product
    Table 84. Zoetis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 85. Zoetis Recent Developments
    Table 86. Advaxis Company Details
    Table 87. Advaxis Business Overview
    Table 88. Advaxis Veterinary Vaccines Product
    Table 89. Advaxis Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 90. Advaxis Recent Developments
    Table 91. AmpliPhi Biosciences Company Details
    Table 92. AmpliPhi Biosciences Business Overview
    Table 93. AmpliPhi Biosciences Veterinary Vaccines Product
    Table 94. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 95. AmpliPhi Biosciences Recent Developments
    Table 96. Aratana Therapeutics Company Details
    Table 97. Aratana Therapeutics Business Overview
    Table 98. Aratana Therapeutics Veterinary Vaccines Product
    Table 99. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 100. Aratana Therapeutics Recent Developments
    Table 101. ARKO Labs Company Details
    Table 102. ARKO Labs Business Overview
    Table 103. ARKO Labs Veterinary Vaccines Product
    Table 104. ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 105. ARKO Labs Recent Developments
    Table 106. Bayer Company Details
    Table 107. Bayer Business Overview
    Table 108. Bayer Veterinary Vaccines Product
    Table 109. Bayer Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 110. Bayer Recent Developments
    Table 111. CanFel Therapeutics Company Details
    Table 112. CanFel Therapeutics Business Overview
    Table 113. CanFel Therapeutics Veterinary Vaccines Product
    Table 114. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 115. CanFel Therapeutics Recent Developments
    Table 116. Ceva Animal Health Company Details
    Table 117. Ceva Animal Health Business Overview
    Table 118. Ceva Animal Health Veterinary Vaccines Product
    Table 119. Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 120. Ceva Animal Health Recent Developments
    Table 121. Colorado Serum Company Details
    Table 122. Colorado Serum Business Overview
    Table 123. Colorado Serum Veterinary Vaccines Product
    Table 124. Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 125. Colorado Serum Recent Developments
    Table 126. Epitopix Company Details
    Table 127. Epitopix Business Overview
    Table 128. Epitopix Veterinary Vaccines Product
    Table 129. Epitopix Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 130. Epitopix Recent Developments
    Table 131. Genus Company Details
    Table 132. Genus Business Overview
    Table 133. Genus Veterinary Vaccines Product
    Table 134. Genus Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 135. Genus Recent Developments
    Table 136. Hygieia Biological Laboratories Company Details
    Table 137. Hygieia Biological Laboratories Business Overview
    Table 138. Hygieia Biological Laboratories Veterinary Vaccines Product
    Table 139. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 140. Hygieia Biological Laboratories Recent Developments
    Table 141. ImmuCell Company Details
    Table 142. ImmuCell Business Overview
    Table 143. ImmuCell Veterinary Vaccines Product
    Table 144. ImmuCell Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 145. ImmuCell Recent Developments
    Table 146. Nexvet Company Details
    Table 147. Nexvet Business Overview
    Table 148. Nexvet Veterinary Vaccines Product
    Table 149. Nexvet Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 150. Nexvet Recent Developments
    Table 151. Nuovo Biologics Company Details
    Table 152. Nuovo Biologics Business Overview
    Table 153. Nuovo Biologics Veterinary Vaccines Product
    Table 154. Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 155. Nuovo Biologics Recent Developments
    Table 156. UBI Company Details
    Table 157. UBI Business Overview
    Table 158. UBI Veterinary Vaccines Product
    Table 159. UBI Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 160. UBI Recent Developments
    Table 161. Valneva Company Details
    Table 162. Valneva Business Overview
    Table 163. Valneva Veterinary Vaccines Product
    Table 164. Valneva Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 165. Valneva Recent Developments
    Table 166. Vetoquinol Company Details
    Table 167. Vetoquinol Business Overview
    Table 168. Vetoquinol Veterinary Vaccines Product
    Table 169. Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 170. Vetoquinol Recent Developments
    Table 171. Virbac Company Details
    Table 172. Virbac Business Overview
    Table 173. Virbac Veterinary Vaccines Product
    Table 174. Virbac Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 175. Virbac Recent Developments
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Veterinary Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. Inactivated Vaccines Features
    Figure 3. Live Attenuated Vaccines Features
    Figure 4. Conjugate Vaccines Features
    Figure 5. Toxoid Vaccines Features
    Figure 6. Recombinant Vaccines Features
    Figure 7. DNA Vaccines Features
    Figure 8. Others Features
    Figure 9. Global Veterinary Vaccines Market Share by Application: 2021 VS 2028
    Figure 10. Veterinary Clinic Case Studies
    Figure 11. Veterinary Hospital Case Studies
    Figure 12. Veterinary Research Institute Case Studies
    Figure 13. Retail Pharmacy Case Studies
    Figure 14. Others Case Studies
    Figure 15. Veterinary Vaccines Report Years Considered
    Figure 16. Global Veterinary Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Veterinary Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Veterinary Vaccines Market Share by Region: 2021 VS 2028
    Figure 19. Global Veterinary Vaccines Market Share by Players in 2021
    Figure 20. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2021
    Figure 22. North America Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. North America Veterinary Vaccines Market Size Market Share by Type (2017-2028)
    Figure 24. North America Veterinary Vaccines Market Size Market Share by Application (2017-2028)
    Figure 25. North America Veterinary Vaccines Market Size Share by Country (2017-2028)
    Figure 26. United States Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Canada Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Europe Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 29. Europe Veterinary Vaccines Market Size Market Share by Type (2017-2028)
    Figure 30. Europe Veterinary Vaccines Market Size Market Share by Application (2017-2028)
    Figure 31. Europe Veterinary Vaccines Market Size Share by Country (2017-2028)
    Figure 32. Germany Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. France Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. U.K. Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Italy Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Russia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Nordic Countries Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 39. Asia Pacific Veterinary Vaccines Market Size Market Share by Type (2017-2028)
    Figure 40. Asia Pacific Veterinary Vaccines Market Size Market Share by Application (2017-2028)
    Figure 41. Asia Pacific Veterinary Vaccines Market Size Share by Region (2017-2028)
    Figure 42. China Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Japan Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. South Korea Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Southeast Asia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. India Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Australia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 48. Latin America Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Latin America Veterinary Vaccines Market Size Market Share by Type (2017-2028)
    Figure 50. Latin America Veterinary Vaccines Market Size Market Share by Application (2017-2028)
    Figure 51. Latin America Veterinary Vaccines Market Size Share by Country (2017-2028)
    Figure 52. Mexico Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Brazil Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Veterinary Vaccines Market Size YoY (2017-2028) & (US$ Million)
    Figure 55. Middle East and Africa Veterinary Vaccines Market Size Market Share by Type (2017-2028)
    Figure 56. Middle East and Africa Veterinary Vaccines Market Size Market Share by Application (2017-2028)
    Figure 57. Middle East and Africa Veterinary Vaccines Market Size Share by Country (2017-2028)
    Figure 58. Turkey Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Saudi Arabia Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. UAE Veterinary Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 63. Merial Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 64. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 65. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 66. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 67. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 68. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 69. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 70. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 71. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 72. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 73. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 74. Genus Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 75. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 76. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 77. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 78. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 79. UBI Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 80. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 81. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 82. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac
Frequently Asked Questions
Veterinary Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Veterinary Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Veterinary Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Vibrating Feeder

Vibrating Feeder market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Vibration Sensors

Vibration Sensors market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More